Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zohar Bassevitch"'
Autor:
Kelly Hu, Jean‐Claude Tardif, Melanie Huber, Maria Daly, Aisha T. Langford, Ruth Kirby, Yves Rosenberg, Judith Hochman, Avni Joshi, Zohar Bassevitch, Michael H. Pillinger, Binita Shah
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 4, Pp 831-837 (2022)
Abstract Randomized controlled trials (RCTs) remain the gold standard to evaluate clinical interventions, producing the highest level of evidence while minimizing potential bias. Inadequate recruitment is a commonly encountered problem that undermine
Externí odkaz:
https://doaj.org/article/41e9f558575e44a1aed3078b6a689dd7
Autor:
Marie-Pierre Dubé, Audrey Lemaçon, Amina Barhdadi, Louis-Philippe Lemieux Perreault, Essaïd Oussaïd, Géraldine Asselin, Sylvie Provost, Maxine Sun, Johanna Sandoval, Marc-André Legault, Ian Mongrain, Anick Dubois, Diane Valois, Emma Dedelis, Jennifer Lousky, Julie Choi, Elisabeth Goulet, Christiane Savard, Lea-Mei Chicoine, Mariève Cossette, Malorie Chabot-Blanchet, Marie-Claude Guertin, Simon de Denus, Nadia Bouabdallaoui, Richard Marchand, Zohar Bassevitch, Anna Nozza, Daniel Gaudet, Philippe L. L’Allier, Julie Hussin, Guy Boivin, David Busseuil, Jean-Claude Tardif
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract We conducted a genome-wide association study of time to remission of COVID-19 symptoms in 1723 outpatients with at least one risk factor for disease severity from the COLCORONA clinical trial. We found a significant association at 5p13.3 (rs
Externí odkaz:
https://doaj.org/article/22ad144ba1304827b38809d5ea8a9606
Autor:
Kelly, Hu, Jean-Claude, Tardif, Melanie, Huber, Maria, Daly, Aisha T, Langford, Ruth, Kirby, Yves, Rosenberg, Judith, Hochman, Avni, Joshi, Zohar, Bassevitch, Michael H, Pillinger, Binita, Shah
Publikováno v:
Clinical and Translational Science. 15:831-837
Randomized controlled trials (RCTs) remain the gold standard to evaluate clinical interventions, producing the highest level of evidence while minimizing potential bias. Inadequate recruitment is a commonly encountered problem that undermines the com
Autor:
Zohar Bassevitch, Anna Nozza, Marie-Pierre Dubé, Maxine Sun, Jennifer Lousky, Julie Hussin, Malorie Chabot-Blanchet, Emma Dedelis, Anick Dubois, Marc-André Legault, Diane Valois, Lea Mei Chicoine, Christiane Savard, Audrey Lemaçon, Johanna Sandoval, Julie Choi, Daniel Gaudet, Ian Mongrain, Sylvie Provost, Louis Philippe Lemieux Perreault, Simon de Denus, R. Marchand, Guy Boivin, Amina Barhdadi, David Busseuil, Nadia Bouabdallaoui, Philippe L. L’Allier, Mariève Cossette, Marie Claude Guertin, Géraldine Asselin, Elisabeth Goulet, Jean-Claude Tardif, Essaïd Oussaïd
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
We conducted a genome-wide association study of time to remission of COVID-19 symptoms in 1723 outpatients with at least one risk factor for disease severity from the COLCORONA clinical trial. We found a significant association at 5p13.3 (rs1173773;
Autor:
Jennifer Lousky, Marie Claude Guertin, Géraldine Asselin, Malorie Chabot-Blanchet, Zohar Bassevitch, Ian Mongrain, Jean-Claude Tardif, Anna Nozza, Christiane Savard, Mariève Cossette, Marc-André Legault, Anick Dubois, Diane Valois, Julie Choi, Marie-Pierre Dubé, Philippe L. L’Allier, Louis Philippe Lemieux Perreault, Sylvie Provost, Lea Mei Chicoine, Essaïd Oussaïd, Audrey Lemaçon, R. Marchand, Daniel Gaudet, Johanna Sandoval, Guy Boivin, Nadia Bouabdallaoui, Simon de Denus, Amina Barhdadi, Julie Hussin, Emma Dedelis, Maxine Sun, David Busseuil, Elisabeth Goulet
We conducted a genome-wide association study of time to remission of COVID-19 symptoms in 1723 outpatients with at least one risk factor for disease severity from the COLCORONA clinical trial. We found a significant association at 5p13.3 (rs1173773;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f444b13fff7670dbac85cc1ecc324e74
https://doi.org/10.1101/2021.02.24.21252396
https://doi.org/10.1101/2021.02.24.21252396
Autor:
Daniel Gaudet, Zohar Bassevitch, Jocelyn Dupuis, Martin Pelletier, Priscilla Y. Hsue, Eve Roy-Clavel, Avni Y. Joshi, Jean Grégoire, Marie-Pierre Dubé, Denis Fortin, André Y. Denault, Christian Lavallée, Mariève Cossette, Norman E. Lepor, Lucie Verret, Michael H. Pillinger, Binita Shah, Marie-Claude Guertin, Chantal Lacoste, Guy Boivin, Protasio da Luz, Elisabeth Goulet, Pierre-Olivier Hétu, Nadia Bouabdallaoui, Sarah Samson, Lambert Busque, Anick Dubois, David D. Waters, Sylvie Levesque, Jose Lopez-Sendon, Jean-Claude Tardif, Anna Nozza, Andreas Orfanos, Sylvia Audet, Philippe L. L’Allier, Malorie Chabot-Blanchet, Jean-Sébastien Paquette, J.C. Tardif, David Busseuil, Philippe A. Tessier, Frédéric Lesage, Nicolas Sainturet
BackgroundEvidence suggests the role of an inflammatory storm in COVID-19 complications. Colchicine is an orally administered, anti-inflammatory medication beneficial in gout, pericarditis and coronary disease.MethodsWe performed a randomized, double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc716ba91947eb6ef2236c303287b68e
https://doi.org/10.1101/2021.01.26.21250494
https://doi.org/10.1101/2021.01.26.21250494